Status:
TERMINATED
Analgesic Effect of rTMS in Vasculitic Neuropathy
Lead Sponsor:
Jagiellonian University
Conditions:
Vasculitic Neuropathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Vasculitic neuropathy (VN) results from inflammation and destruction of the walls of predominantly small vessels with subsequent ischemic damage of peripheral nerves. VN is painful in vast majority of...
Detailed Description
Vasculitic neuropathies (VN) are a group of disorders resulting from inflammation of predominantly small vessels with destruction of their walls and subsequent ischemic damage of peripheral nerves. Ne...
Eligibility Criteria
Inclusion
- Diagnosis of vasculitic neuropathy
- Neuropathic pain of constant severity since not less than a month and requiring use of analgesics more than once a week
- Score of 30 milimeter or more on the 100 milimeter visual analog scale of pain intensity at inclusion
Exclusion
- Severe depression
- Personality disorders and other psychiatric conditions, which could disturb the participation in the study
- Cognitive deficits, which could disturb the participation in the study
- Contraindications for rTMS as listed by the Guidelines of the International Federation of Clinical Neurophysiology (Rossi et al. 2009) i.e. seizure in the past, epilepsy, presence of magnetic material in the reach of magnetic field, pregnancy, likelihood to get pregnant, intracranial electrodes, cardiac pacemaker or intracardiac lines, frequent syncopes
Key Trial Info
Start Date :
January 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 21 2023
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04720196
Start Date
January 25 2021
End Date
September 21 2023
Last Update
October 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jagiellonian University Medical College, Department of Neurology
Krakow, Poland, 31503